Loss of RND3/RHOE controls entosis through LAMP1 expression in hepatocellular carcinoma

Sara Basbous,Lydia Dif,Camille Dantzer,Sylvaine Di-Tommaso,Jean-William Dupuy,Paulette Bioulac-Sage,Anne-Aurélie Raymond,Chantal Desdouets,Frédéric Saltel,Violaine Moreau

DOI: https://doi.org/10.1038/s41419-024-06420-3

2024-01-14

Cell Death and Disease

Abstract:Entosis is a process that leads to the formation of cell-in-cell structures commonly found in cancers. Here, we identified entosis in hepatocellular carcinoma and the loss of Rnd3 (also known as RhoE) as an efficient inducer of this mechanism. We characterized the different stages and the molecular regulators of entosis induced after Rnd3 silencing. We demonstrated that this process depends on the RhoA/ROCK pathway, but not on E-cadherin. The proteomic profiling of entotic cells allowed us to identify LAMP1 as a protein upregulated by Rnd3 silencing and implicated not only in the degradation final stage of entosis, but also in the full mechanism. Moreover, we found a positive correlation between the presence of entotic cells and the metastatic potential of tumors in human patient samples. Altogether, these data suggest the involvement of entosis in liver tumor progression and highlight a new perspective for entosis analysis in medicine research as a novel therapeutic target.

cell biology

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve

This paper aims to investigate the mechanisms of entosis in hepatocellular carcinoma (HCC) and its relationship with the loss of RND3 expression. Specifically:

1. **Triggers of Entosis**: The paper explores whether hepatocellular carcinoma cells form entotic structures under conditions such as nutrient deprivation and matrix detachment. The study finds that under these stress conditions, hepatocellular carcinoma cells indeed undergo entosis.

2. **Role of RND3 Expression Loss**: Researchers discovered that the loss of RND3 gene expression significantly promotes entosis in hepatocellular carcinoma cells. Further studies indicate that this effect is dependent on the RhoA/ROCK signaling pathway but not on E-cadherin.

3. **Role of LAMP1**: Through proteomic analysis, researchers identified LAMP1 as a key protein upregulated following the loss of RND3. LAMP1 is not only involved in the degradation stage of entosis but also plays an important role throughout the entire entosis process.

4. **Clinical Relevance**: The paper also examines the presence of entosis in samples from HCC patients and its association with tumor invasion characteristics. The results show that entotic events are related to HCC progression, particularly in tumors with satellite nodules or vascular invasion.

In summary, this paper systematically studies the impact of RND3 expression loss on entosis in hepatocellular carcinoma cells, revealing the potential role of entosis in HCC progression and proposing LAMP1 as a possible therapeutic target.